Dear Friends and Colleagues,

We are hosting the 8th TREAT-NMD® International Conference focusing on translational medicine in inherited neuromuscular diseases from the 10th – 12th February 2026 in Lisbon, Portugal.

TREAT-NMD 2026 is not just a conference—it’s a vital, in-person gathering where patients, clinicians, researchers, industry, and regulators come together to tackle the biggest challenges in neuromuscular treatment development, diagnosis and care. Topics will include; disrupted clinical trial delivery, regulatory uncertainty, global access inequalities and shrinking public funding, we’ll tackle these themes with a holistic, solutions-driven approach and a patient centric and global focus.

Built around open discussion and real solution-building, this is where the future of rare disease care gets shaped.

The conference will attract around 300 delegates including academics, patients and carers, patient advocacy organisations and clinical specialists. Industry professionals will have the platform to:

• Network with partners on key issues and challenges in neuromuscular disease.
• Engage with panels of international experts who will inform, challenge and stimulate discussions.
• Acquire the latest updates on standards of care, outcome measures, patient registries and new developments including addressing trial site capacity.

We have a variety of sponsorship opportunities available for our industry partners; featuring a wide range of options giving sponsors on-going visibility throughout the conference. We are confident that our meeting will provide you with an excellent setting to promote your research and therapeutic advancements to a wide community of clinicians, patients and other partners.

We look forward to your participation in the 8th TREAT-NMD International Conference and hope that you will be able to support us in delivering a truly unique event for the neuromuscular community.

Yours sincerely,
Professor Annemieke Aartsma-Rus, and
Professor Heather Gordish-Dressman

(Conference Co-Chairs)